Home>Topics>Stocks>Medicines

Medicines MDCO

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines

    Related Topics:

    1. The Medicines' CEO Presents at Deutsche Bank Annual Healthcare Conference (Transcript)

      Headlines

      Mon, 7 May 2012

      The Medicines Company ( MDCO ) Deutsche Bank Annual Healthcare Conference Call May 7, 2012 2:10 pm ET Executives Clive A. Meanwell – Chairman and Chief

    2. Top March 2012 Quarter Picks From $1 Billion Pure-Play Biotech Swiss Hedge Fund BB Biotech

      Headlines

      Mon, 7 May 2012

      By Ganaxi Small Cap Movers : Switzerland-based BB Biotech, founded in 1993, is one of the largest pure-play biotech investment companies, and also a public company with its shares are listed on the Swiss Stock Market. About a third of its assets are invested in oncology-focused biotech companies,

    3. Analyzing Noteworthy Insider Trades Last Week In Regeneron, Covidien, And Other Healthcare Stocks

      Headlines

      Mon, 7 May 2012

      By Ganaxi Small Cap Movers : We present here two noteworthy insider buys and eight noteworthy insider sells in the healthcare sector from Wednesday through Friday's (May 2nd, 3rd, and 4th, 2012) over 1,100 separate SEC Form 4 (insider trading) filings, as part of our daily and weekly coverage of ...

    4. Large, Diverse Pipelines At Small Biotech Companies

      Headlines

      Tue, 13 Mar 2012

      By ScriptVolume : As discussed in earlier parts of this series (starting with part one ), risk mitigation is crucial in successful small biotech investing and key to this strategy is finding companies with big, robust pipelines. Ligand Pharmaceuticals ( LGND ) and Isis Pharmaceuticals ( ISIS ) with

    5. Medicines Company ( MDCO ): Q4 EPS of $0.52 beats by $0.28. Revenue of $132.2M (+10.4% Y/Y) beats by $7M. Shares +5.6% premarket. (PR)

      Headlines

      Wed, 22 Feb 2012

      Medicines Company ( MDCO ): Q4 EPS of $0.52 beats by $0.28 . Revenue of $132.2M (+10.4% Y/Y) beats by $7M . Shares +5.6% premarket. ( PR ) Post your comment!

    6. Medicines MDCO Q4 2011 Earnings Call Transcript

      Headlines

      Wed, 22 Feb 2012

      Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Full Year 2011 The Medicines Company Earnings Conference Call. My name is Fab and I will be your operator for today. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session.

    7. 16 Rallying Healthcare Stocks Being Sold By Hedge Funds

      Headlines

      Tue, 21 Feb 2012

      By Kapitall : Smart money buying trends can be very interesting to follow, especially when they seem to disagree with recent market behavior. If a stock is rallying but institutional managers are selling the name, for instance, it might indicate you should give it a closer look. We ran a screen on

    8. Analyzing Soros Fund Management's Top 7 Buys

      Headlines

      Sun, 20 Nov 2011

      Change in shares Amazon.com Inc. AMZN 12745 206016 193271 Motorola Solutions Inc. MSI 5662139 6596337 934198 Medicines Co. MDCO 0 1700000 1700000 Interoil Corporation IOC 3969622 4394622 425000 Biogen Idec Inc. BIIB 0 201000 201000 Sandisk Corp. SNDK

    9. Ligand Pharmaceuticals' Insider Buys Continue Ahead Of New Catalysts

      Headlines

      Wed, 2 Nov 2011

      By M.E. Garza : Shares of Ligand Pharmaceuticals ( LGND ) have continued to climb since we first reported in August that insider buying in the stock was on the rise. Shares were trading at approximately $12 per share at the time of that report and rose to a 52 Week-High of $16.24. Shares are ...

    10. The Medicines Company Needs More Options Beyond Angiomax

      Headlines

      Wed, 12 Oct 2011

      By EP Vantage : Things are looking up for The Medicines Company ( MDCO ) ( from here, "TMC ") once more. Shares in the New Jersey group gained 17% last week to $17.37 following a patent litigation

    « Prev1234Next »
    Content Partners